The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of intratumoral administration of CF33-HNIS-antiPDL1 in patients with metastatic triple negative breast cancer.
 
Yuan Yuan
Consulting or Advisory Role - BCI Pharma; Diiachi; Eisai; Genentech; Guardant Health; Immunomedics; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Lilly; Eisai; Genentech
Research Funding - Genentech; Imugene; Merck; Novartis; Pfizer
Expert Testimony - Novartis
 
Jianying Zhang
No Relationships to Disclose
 
Jonathan Kessler
Consulting or Advisory Role - AngioDynamics
Research Funding - Philips Healthcare
 
Jamie Rand
No Relationships to Disclose
 
Badri Modi
No Relationships to Disclose
 
Shyambabu Chaurasiya
No Relationships to Disclose
 
Mireya Murga
No Relationships to Disclose
 
Aileen Tang
No Relationships to Disclose
 
Norma Martinez
No Relationships to Disclose
 
Hans Meisen
No Relationships to Disclose
 
Dave Yamauchi
No Relationships to Disclose
 
Susan Elaine Yost
No Relationships to Disclose
 
Leslie Mi Ok Chong
Employment - Imugene
Leadership - Chimeric Therapeutics; Imugene
Stock and Other Ownership Interests - Chimeric Therapeutics; Imugene
Patents, Royalties, Other Intellectual Property - Imugene
 
Amanda Seiz
Employment - Imugene
Stock and Other Ownership Interests - Imugene
Consulting or Advisory Role - IAA Consulting
 
Bonnie Nixon
Employment - Imugene
Stock and Other Ownership Interests - Chimeric Therapeutics (I); Imugene
Patents, Royalties, Other Intellectual Property - Imugene (Inst)
 
Nicholas Ede
Employment - Imugene
Leadership - Imugene
Stock and Other Ownership Interests - Imugene
 
James Ross Waisman
No Relationships to Disclose
 
Daphne B. Stewart
No Relationships to Disclose
 
Joanne E. Mortimer
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Pfizer; Puma Biotechnology
 
Yuman Fong
Stock and Other Ownership Interests - Imugene; Pfizer (I)
Consulting or Advisory Role - Imugene; Johnson & Johnson; Medtronic; Perfint Healthcare; Sangamo Bioscience; Vergent Bioscience
Patents, Royalties, Other Intellectual Property - Viral Vector licensed to Imugene; Viral vector licensed to Merck